Get the Science

Nine Lifestyle Factors May Lower Your Alzheimer’s Risk

Nine Lifestyle Factors May Lower Your Alzheimer’s Risk

Last month, the Lancet Commission on Dementia Prevention, Intervention, and Care reported that 35% of dementia cases could be prevented by fully addressing nine lifestyle factors [1].

The risk factors follow, in order of the percent of dementia cases that could be prevented by eliminating them.


Studies have suggested that even mild levels of hearing loss may increase the long-term risk of cognitive decline and dementia [1]. An analysis across three studies showed that hearing loss in midlife is associated with an almost two-fold increased risk for dementia [2][3][4]. It is possible that hearing loss promotes the development of dementia, or the changes dementia produces in the brain impairs hearing function, or both. Hearing loss may also lead to social isolation or depression, both of which are also associated with dementia risk (see below). Hearing loss may be corrected with the use of hearing aids.


Not attending secondary school also increases your risk of dementia [1]. Low educational levels can make you more vulnerable to cognitive decline, because it results in less "cognitive reserve" that allows you to maintain cognitive function despite brain aging and even beta-amyloid plaques in some cases. In contrast, lifelong learning is associated with improved brain health, and higher levels of cognitive activity at mid- or late-life are linked to delayed onset of cognitive impairment [5].


Cigarettes and cigarette smoke contain more than 4,700 chemical compounds, including some that are highly toxic [6]. Observational studies have shown that people who smoke are at higher risk of developing all types of dementia and a much higher risk (up to 79%) for Alzheimer's disease, specifically [7]. The good news is that quitting can reduce your risk of dementia, because current smokers have a higher risk than former smokers [7][8].


Research indicates that depressive episodes are linked to higher dementia risk—and this association appears most prominent in late-life [9][10]. Depression may heighten dementia risk by increasing stress hormones, decreasing levels of proteins that are good for brain cells, and shrinking the hippocampus, a brain region critical for forming memory [11][12]. There are preliminary studies suggesting that some antidepressants may decrease markers of Alzheimer's disease [13].


Exercisers are less likely to develop dementia, particularly Alzheimer's disease [14][15]. There are many ways that exercise might benefit brain health. It reduces chronic inflammation, increases the release of a protein that is very good for brain cells [16], and improves cardiovascular and metabolic health [17][18]. The World Health Organization recommends that adults get at least 150 minutes of moderate-intensity (or 75 minutes of vigorous-intensity) aerobic exercise every week, along with at least two days of muscle-strengthening activities [19].


Social isolation is a risk factor not only for dementia but also for hypertension, coronary heart disease, and depression [1]. Low social participation, fewer social contacts, and more loneliness have all been associated with increased dementia risk [20]. Social isolation may result in decreased cognitive activity, which may accelerate cognitive decline and poor mood. It is recommended that you maintain social contacts throughout life and participate in engaging group activities.


Studies suggest that having hypertension in middle age increases the risk of both vascular dementia and Alzheimer's disease [21][22]. Even in later years, keeping hypertension under control may protect against cognitive decline [23]. An analysis of several studies found that people who managed their hypertension had a lower risk of dementia and higher cognitive function overall than those with uncontrolled hypertension [24]. Hypertension can be managed through diet, lifestyle changes, and medications.


Epidemiological studies have reported that people who are obese in midlife have an increased risk of dementia compared to those with healthy body weight [25]. Obesity increases risk for diabetes and hypertension, both of which are associated with increased risk of dementia (see above and below). A study in people with mild cognitive impairment reported that normal body mass index (BMI under 25), greater physical activity, and healthier diet were associated with lower levels of plaques and tangles, which are markers of Alzheimer's disease [26].


People with diabetes have up to 73% increased risk of dementia and a 100% higher risk of developing vascular dementia than non-diabetics [27-30]. Type 2 diabetes and Alzheimer’s disease share some characteristics, such as impaired insulin signaling and oxidative stress [31]. Because of this, research is underway to evaluate whether some specific diabetes drugs can prevent dementia even in patients without diabetes [32-35]. A healthy diet, exercise, and weight control are the first steps of diabetes management, and effectively managing diabetes is critical for long-term brain health.

The Lancet report is good news. There are concrete steps you can take to reduce dementia risk, such as investing in lifelong learning and friendships, exercising, maintaining a healthy weight, quitting smoking, and seeking treatment for depression, hypertension, diabetes, and hearing loss if you have these conditions.

BBC World News interviewed Howard Fillit, MD, the Founding Executive Director of Alzheimer's Drug Discovery Foundation, about the Lancet report findings.


  1. Livingston G, Sommerlad A, Orgeta V et al. (2017) Dementia prevention, intervention, and care. Lancet.
  2. Deal JA, Betz J, Yaffe K et al. (2017) Hearing Impairment and Incident Dementia and Cognitive Decline in Older Adults: The Health ABC Study. J Gerontol A Biol Sci Med Sci 72, 703-709.
  3. Gallacher J, Ilubaera V, Ben-Shlomo Y et al. (2012) Auditory threshold, phonologic demand, and incident dementia. Neurology 79, 1583-1590.
  4. Lin FR, Metter EJ, O'Brien RJ et al. (2011) Hearing loss and incident dementia. Arch Neurol 68, 214-220.
  5. Vemuri P, Lesnick TG, Przybelski SA et al. (2014) Association of lifetime intellectual enrichment with cognitive decline in the older population. JAMA Neurol 71, 1017-1024.
  6. Swan GE, Lessov-Schlaggar CN (2007) The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 17, 259-273.
  7. Barnes DE, Yaffe K (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10, 819-828.
  8. Durazzo TC, Mattsson N, Weiner MW et al. (2016) Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal Elders. Nicotine Tob Res 18, 204-211.
  9. Dotson VM, Beydoun MA, Zonderman AB (2010) Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology 75, 27-34.
  10. Singh-Manoux A, Dugravot A, Fournier A et al. (2017) Trajectories of Depressive Symptoms Before Diagnosis of Dementia: A 28-Year Follow-up Study. JAMA Psychiatry 74, 712-718.
  11. Lupien SJ, McEwen BS, Gunnar MR et al. (2009) Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10, 434-445.
  12. Geerlings MI, Gerritsen L (2017) Late-Life Depression, Hippocampal Volumes, and Hypothalamic-Pituitary-Adrenal Axis Regulation: A Systematic Review and Meta-analysis. Biol Psychiatry 82, 339-350.
  13. Sheline YI, West T, Yarasheski K et al. (2014) An antidepressant decreases CSF Abeta production in healthy individuals and in transgenic AD mice. Sci Transl Med 6, 236re234.
  14. Blondell SJ, Hammersley-Mather R, Veerman JL (2014) Does physical activity prevent cognitive decline and dementia?: A systematic review and meta-analysis of longitudinal studies. BMC Public Health 14, 510.
  15. Hamer M, Chida Y (2009) Physical activity and risk of neurodegenerative disease: a systematic review of prospective evidence. Psychol Med 39, 3-11.
  16. Jensen CS, Hasselbalch SG, Waldemar G et al. (2015) Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives. Front Neurol 6, 187.
  17. DeRight J, Jorgensen RS, Cabral MJ (2015) Composite cardiovascular risk scores and neuropsychological functioning: a meta-analytic review. Ann Behav Med 49, 344-357.
  18. Way KL, Hackett DA, Baker MK et al. (2016) The Effect of Regular Exercise on Insulin Sensitivity in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Metab J 40, 253-271.
  19. (2010) Global strategy on diet, physical activity, and health: Physical activity and adults. WHO.
  20. Kuiper JS, Zuidersma M, Oude Voshaar RC et al. (2015) Social relationships and risk of dementia: A systematic review and meta-analysis of longitudinal cohort studies. Ageing Res Rev 22, 39-57.
  21. Di Bari M, Pahor M, Franse LV et al. (2001) Dementia and disability outcomes in large hypertension trials: lessons learned from the systolic hypertension in the elderly program (SHEP) trial. Am J Epidemiol 153, 72-78.
  22. Roman GC, Nash DT, Fillit H (2012) Translating current knowledge into dementia prevention. Alzheimer Dis Assoc Disord 26, 295-299.
  23. Parsons C, Murad MH, Andersen S et al. (2016) The effect of antihypertensive treatment on the incidence of stroke and cognitive decline in the elderly: a meta-analysis. Future Cardiol 12, 237-248.
  24. Levi Marpillat N, Macquin-Mavier I, Tropeano AI et al. (2013) Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens 31, 1073-1082.
  25. Albanese E, Launer LJ, Egger M et al. (2017) Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies. Alzheimers Dement (Amst) 8, 165-178.
  26. Merrill DA, Siddarth P, Raji CA et al. (2016) Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints. Am J Geriatr Psychiatry 24, 729-737.
  27. Chatterjee S, Peters SA, Woodward M et al. (2016) Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia. Diabetes Care 39, 300-307.
  28. Deckers K, van Boxtel MP, Schiepers OJ et al. (2015) Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry 30, 234-246.
  29. Gudala K, Bansal D, Schifano F et al. (2013) Diabetes mellitus and risk of dementia: A meta-analysis of prospective observational studies. J Diabetes Investig 4, 640-650.
  30. Vagelatos NT, Eslick GD (2013) Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship. Epidemiol Rev 35, 152-160.
  31. Sebastiao I, Candeias E, Santos MS et al. (2014) Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia. Front Endocrinol (Lausanne) 5, 110.
  32. Arnold SE Effect of Insulin Sensitizer Metformin on AD Biomarkers. ClinicalTrialsgov.
  33. Edison P Evaluating Liraglutide in Alzheimer's Disease (ELAD).
  34. Kapogiannis DI A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease. ClinicalTrialsgov.
  35. Takeda Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset (TOMORROW).

Yuko Hara, PhD, is Director of Aging and Alzheimer's Prevention at the Alzheimer's Drug Discovery Foundation. Dr. Hara was previously an Assistant Professor in Neuroscience at the Icahn School of Medicine at Mount Sinai, where she remains an adjunct faculty member. Her research focused on brain aging, specifically how estrogens and reproductive aging influence the aging brain's synapses and mitochondria. She earned a doctorate in neurology and neuroscience at Weill Graduate School of Medical Sciences of Cornell University and a bachelor's degree in biology from Cornell University, with additional study at Keio University in Japan. Dr. Hara has authored numerous peer-reviewed publications, including articles in PNAS and Journal of Neuroscience.

Get the latest brain health news: